Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint InhibitorsCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent ChemoradiationNikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer|January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab eraMichelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2023
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidationNikhil Yegya-Raman, Sang Ho Lee, Cole Friedes, et al.
Pageof 2